NCT06587334

Brief Summary

The goal of this clinical trial is to learn if Neodymium-Doped Yttrium Aluminum Garnet(Nd: YAG) Laser-assisted non-surgical periodontal treatment is effective in treating stage II/III periodontitis. It will also evaluate the safety and impact of the laser treatment. The main questions it aims to answer are:

  1. 1.Does Nd: YAG Laser treatment reduce probing depth, gingival inflammation, and clinical attachment loss more effectively than standard Scaling and root planing(SRP) therapy alone?
  2. 2.What changes in inflammatory markers and oxidative stress levels occur when patients receive laser-assisted therapy? Researchers will compare Nd: YAG Laser treatment to standard periodontal therapy alone to determine the effectiveness of the laser treatment.
  3. 3.Receive Nd: YAG Laser assisted therapy on one side of their mouth and standard therapy on the other side.
  4. 4.Visit the clinic at baseline, 6 weeks, and 3 months for follow-up assessments and tests.
  5. 5.Provide samples and have measurements taken of periodontal health and biomarkers of inflammation and oxidative stress.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

September 4, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2024

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

September 20, 2024

Status Verified

May 1, 2024

Enrollment Period

4 months

First QC Date

September 4, 2024

Last Update Submit

September 18, 2024

Conditions

Keywords

Nd: YAG LaserPeriodontitis

Outcome Measures

Primary Outcomes (1)

  • Probing depth,PD

    Probing depth refers to the distance from the gingival margin to the base of the periodontal pocket. It is measured using a periodontal probe at multiple sites around each tooth. A reduction in probing depth is indicative of periodontal health improvement following treatment.

    Baseline,6 weeks,3months

Secondary Outcomes (5)

  • Gingival index,GI

    Baseline,6 weeks,3months

  • Clinical attachment loss,CAL

    Baseline,6 weeks,3months

  • Concentration of interleukin-6(IL-6)

    Baseline,6 weeks,3months

  • Concentration of tumor necrosis factor-alpha(TNF-α)

    Baseline,6 weeks,3months

  • Concentration of malondialdehyde(MDA)

    Baseline,6 weeks,3months

Study Arms (2)

Control Group

ACTIVE COMPARATOR

The control group will receive SRP alone

Procedure: SRP

Laser Group

EXPERIMENTAL

The laser group will receive SRP combined with Nd laser-assisted therapy

Procedure: Nd: YAG Laser Assisted SRP

Interventions

SRPPROCEDURE

SRP alone

Control Group

the patients receive SRP combined with Nd: YAG laser

Laser Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 65 years, with no gender restrictions.
  • Diagnosed with stage II or III periodontitis according to the 2018 Classification of Periodontal and Peri-Implant Diseases and Conditions.
  • In each of the four quadrants of the oral cavity, at least one tooth must have at least one site with a probing depth ≥5 mm, clinical attachment loss ≥2 mm, and bleeding on probing.
  • Participants must provide informed consent and sign the informed consent form.

You may not qualify if:

  • Fewer than 20 remaining teeth (10 pairs of opposing teeth) or a significant discrepancy in the number of remaining teeth between the left and right sides of the mouth.
  • Patients who have undergone periodontal treatment within the past six months or are currently undergoing orthodontic treatment, which may affect periodontal health.
  • Patients with systemic diseases that could influence the outcomes of periodontal treatment.
  • Patients with severe infections, malignancies, or other major diseases affecting overall health.
  • Pregnant or breastfeeding women.
  • Individuals with a history of smoking.
  • Patients who are unable to comply with or complete periodontal treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310009, China

RECRUITING

Related Publications (1)

  • Bian Z, Zhang H, Chen Y, Yang Y, Lin Q, Chen X, Chen L, Sun W, Tan J. Clinical effect of Nd:YAG laser-assisted non-surgical periodontal treatment on stage II/III periodontitis. J Dent. 2025 Nov;162:106056. doi: 10.1016/j.jdent.2025.106056. Epub 2025 Aug 26.

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Jingyi Tan, Doctor

    Second Affiliated Hospital, School of Medicine, Zhejiang University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jingyi Tan, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: The study adopts a split-mouth design with each subject serving as their own control. A random number method is used to determine whether the left or right half of the mouth will be assigned to the laser group, with the remaining half assigned to the control group. The laser group will receive SRP combined with Nd laser-assisted therapy, while the control group will receive SRP alone.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2024

First Posted

September 19, 2024

Study Start

September 4, 2024

Primary Completion

December 20, 2024

Study Completion

December 30, 2024

Last Updated

September 20, 2024

Record last verified: 2024-05

Locations